EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma

Maria C Ferrández, Sandeep S V Golla, Jakoba J Eertink, Sanne E Wiegers, Gerben J C Zwezerijnen, Martijn W Heymans, Pieternella J Lugtenburg, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Sally F Barrington und 9 weitere

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.268191 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Maria C Ferrández und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; m.c.f…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to validate a previously developed deep learning model in 5 independent clinical trials. The predictive performance of this model was compared with the international prognostic index (IPI) and 2 models incorporating radiomic PET/CT features (clinical PET and PET models).

Methods

In total, 1,132 diffuse large B-cell lymphoma patients were included: 296 for training and 836 for external validation. The primary outcome was 2-y time to progression. The deep learning model was trained on maximum-intensity projections from PET/CT scans. The clinical PET model included metabolic tumor volume, maximum distance from the bulkiest lesion to another lesion, SUVpeak, age, and performance status. The PET model included metabolic tumor volume, maximum distance from the bulkiest lesion to another lesion, and SUVpeak Model performance was assessed using the area under the curve (AUC) and Kaplan-Meier curves.

Results

The IPI yielded an AUC of 0.60 on all external data. The deep learning model yielded a significantly higher AUC of 0.66 (P 0.05). The PET model yielded the highest AUC of all models (AUC, 0.71; P < 0.05).

Conclusion

The deep learning model predicted outcome in all trials with a higher performance than IPI and better survival curve separation. This model can predict treatment outcome in diffuse large B-cell lymphoma without tumor delineation but at the cost of a lower prognostic performance than with radiomics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffusePositron Emission Tomography Computed TomographyHumansMaleFemaleMiddle AgedAgedDeep LearningImage Processing, Computer-AssistedPrognosisArtificial IntelligenceAdult

Stichwörter der Autor:innen

convolutional neural networksdiffuse large B-cell lymphomamaximum-intensity projectionpredictiontime to progression

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; m.c.ferrandezferrandez@amsterdamumc.nl.
  • Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Zitieren

APA

Ferrández, M. C., Golla, S. S. V., Eertink, J. J., Wiegers, S. E., Zwezerijnen, G. J. C., Heymans, M. W., Lugtenburg, P. J., Kurch, L., Hüttmann, A., Hanoun, C., Dührsen, U., Barrington, S. F., Mikhaeel, N. G., Ceriani, L., Zucca, E., Czibor, S., Györke, T., Chamuleau, M. E. D., Zijlstra, J. M., …, & PETRA Consortium (2024). Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268191

Vancouver

Ferrández MC, Golla SSV, Eertink JJ, Wiegers SE, Zwezerijnen GJC, Heymans MW, et al. Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.268191

BibTeX
@article{Ferrndez2024,
  author = {Ferrández, Maria C and Golla, Sandeep S V and Eertink, Jakoba J and Wiegers, Sanne E and Zwezerijnen, Gerben J C and Heymans, Martijn W and Lugtenburg, Pieternella J and Kurch, Lars and Hüttmann, Andreas and Hanoun, Christine and Dührsen, Ulrich and Barrington, Sally F and Mikhaeel, N George and Ceriani, Luca and Zucca, Emanuele and Czibor, Sándor and Györke, Tamás and Chamuleau, Martine E D and Zijlstra, Josée M and Boellaard, Ronald and PETRA Consortium, PETRA Consortium},
  title = {Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.268191}
}
Kostenlos starten →